FDA Import Refusal SCS-7296396-1/21/1 — Eli Lilly Canada Inc
The FDA refused shipment SCS-7296396-1/21/1 from Eli Lilly Canada Inc (Canada) on Nov 7, 2019. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 7, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDK17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75